PharmaSGP Holding SE Total Liabilities

Latest as of March 2025: €81.51 Million EUR ≈ $95.29 Million USD

PharmaSGP Holding SE total liabilities. Based on the latest financial reports, PharmaSGP Holding SE (PSG) has total liabilities worth €81.51 Million EUR (≈ $95.29 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PSG asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of PharmaSGP Holding SE (2014–2024)

Total liabilities of PharmaSGP Holding SE from 2014 to 2024. This chart illustrates how PharmaSGP Holding SE's total liabilities have evolved over time, based on quarterly financial data. Explore PharmaSGP Holding SE long-term investment allocation to see how much of total assets are deployed in long-term investments.

PharmaSGP Holding SE Competitors by Total Liabilities

The table below lists competitors of PharmaSGP Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
Baader Bank Aktiengesellschaft F:BWB	Germany	€4.09 Billion
Hangzhou Heshun Technology Co.LTD. SHE:301237	China	CN¥609.85 Million
Ind-Swift Laboratories Limited NSE:INDSWFTLAB	India	Rs2.37 Billion
Jiangsu Smartwin Electronics Technology Co.Ltd. SHE:301106	China	CN¥456.76 Million
Paz Corp SN:PAZ	Chile	CL$448.53 Billion
Fullink Technology Co. LTD. SHE:301067	China	CN¥303.04 Million
Leadtek Research Inc TW:2465	Taiwan	NT$697.72 Million
Sofwave Medical Ltd TA:SOFW	Israel	ILA22.97 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PharmaSGP Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PSG current and non-current assets.

Liquidity & Leverage Metrics

PharmaSGP Holding SE Total Liabilities Ratios Explained

PharmaSGP Holding SE total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaSGP Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaSGP Holding SE (2014–2024)

The table below shows the annual total liabilities of PharmaSGP Holding SE from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	€82.31 Million ≈ $96.23 Million	-10.09%
2023-12-31	€91.55 Million ≈ $107.03 Million	-6.60%
2022-12-31	€98.01 Million ≈ $114.59 Million	+5.32%
2021-12-31	€93.06 Million ≈ $108.80 Million	+592.58%
2020-12-31	€13.44 Million ≈ $15.71 Million	+64.65%
2019-12-31	€8.16 Million ≈ $9.54 Million	-63.05%
2017-12-31	€22.09 Million ≈ $25.82 Million	-1.69%
2016-12-31	€22.47 Million ≈ $26.27 Million	-4.22%
2015-12-31	€23.46 Million ≈ $27.42 Million	+16.53%
2014-12-31	€20.13 Million ≈ $23.53 Million	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14066 Global

#1438 in Germany

Share Price

€28.80

Change (1 day)

+0.00%

52-Week Range

€28.80 - €28.80

All Time High

€32.32